clinical-trials-2017-scientifictracks-abstracts

45 / 46

Page 88
Notes:
conferenceseries.com
Volume 7, Issue 5 (Suppl) J Clin Trials, an open access journal
ISSN:2167-0870 Clinical Trials 2017
September 11-13, 2017
September 11-13, 2017 San Antonio, USA
4th International Conference on
Cl inical Tr ial s
The role of palliative care on phase 1 oncology clinical trial participants
Amanda M Brock
University of Pennsylvania, USA
Integration of Palliative Care into oncology care has been a challenge since the inception of palliative care programs. Phase 1
oncology clinical trial participants are considered a distinctly vulnerable population. They are at high risk for lack of follow
through by the healthcare system after being withdrawn from the clinical trial. In addition, they are at risk for therapeutic
misconception and major challenges associated with dual enrollment on the trial and hospice programs. Patients with dual
enrollment in palliative care and phase 1 trials could live longer lives, remain on trials for longer, have higher rates of advance
directive completion, and may be more likely to die comfortably at home. Palliative Care consultation upon phase 1 trial
enrollment can could improve the quality of the research being conducted as well as improve Quality of Life for trial participants.
Biography
Amanda M Brock has completed her Master of Bioethics and Master of Science in Nursing at the University of Pennsylvania. She has ten years’ experience in direct
patient care including inpatient and outpatient, nursing administration, and clinical research. She is experienced in leading committee work and creating nursing
policies. She is a firm believer in systems thinking and the importance of clear and thoughtful communication in clinical care.
Amanda M Brock, J Clin Trials 2017, 7:5 (Suppl)
DOI: 10.4172/2167-0870-C1-019